Digital Clock Drawing as an Alzheimer’s Disease Susceptibility Biomarker: Associations with Genetic Risk Score and APOE in Older Adults - 21/11/24

Doi : 10.14283/jpad.2023.48 
Louisa I. Thompson 1, , M. Cummings 2, S. Emrani 1, D.J. Libon 3, A. Ang 2, C. Karjadi 2, R. Au 2, 4, C. Liu 5
1 Dept. of Psychiatry & Human Behavior, Alpert Medical School, Brown University, 345 Blackstone Blvd., 02906, Providence, RI, USA 
2 Dept. of Anatomy & Neurobiology, Boston University Medical School, Boston, MA, USA 
3 Dept. of Geriatrics, Gerontology, and Psychology, New Jersey Institute for Successful Aging, School of Osteopathic Medicine, Rowan University, Glassboro, New Jersey, USA 
4 Framingham Heart Study, Boston University Medical School, Boston, MA, USA 
5 Dept. of Biostatistics, Boston University School of Public Health, Boston, MA, USA 

a louisa_thompson@brown.edu louisa_thompson@brown.edu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

Alzheimer’s disease (AD) is the leading cause of dementia in older adults, but most people are not diagnosed until significant neuronal loss has likely occurred along with a decline in cognition. Non-invasive and cost-effective digital biomarkers for AD have the potential to improve early detection.

Objective

We examined the validity of DCTclock™ (a digitized clock drawing task) as an AD susceptibility biomarker.

Design

We used two primary independent variables, Apolipoprotein E (APOE) ε4 allele carrier status and polygenic risk score (PRS). We examined APOE and PRS associations with DCTclock™ composite scores as dependent measures.

Setting

We used existing data from the Framingham Heart Study (FHS), a community-based study with the largest dataset of digital clock drawing data to date.

Participants

The sample consisted of 2,398 older adults ages 60–94 with DCTclock™ data (mean age of 72.3, 55% female and 92% White).

Measurements

PRS was calculated using 38 variants identified in a recent large genome-wide association study (GWAS) and meta-analysis of late-onset AD (LOAD).

Results

Results showed that DCTclock™ performance decreased with advancing age, lower education, and the presence of one or more copies of APOE ε4. Lower DCTclock™ Total Score as well as lower composite scores for Information Processing Speed (both command & copy conditions) and Drawing Efficiency (command condition) were significantly associated with higher PRS levels and more copies of APOE ε4. APOE and PRS associations displayed similar effect sizes in both men and women.

Conclusions

Our results indicate that higher AD genetic risk is associated with poorer DCTclock™ performance in older adults without dementia. This is the first study to demonstrate significant differences in clock drawing performance on the basis of APOE status or PRS.

Le texte complet de cet article est disponible en PDF.

Key words : Genetics, polygenic risk score, APOE, cognitive screening, clock drawing test, digital biomarkers


Plan


 Both authors contributed equally and share co-first authorship
An Erratum to this article is available online at jpad.2023.93.
Disclosures
David Libon receives royalties from Linus Heath and Oxford University Press. Rhoda Au serves as a scientific advisor to Signant Health and a scientific consultant to Biogen Inc. All other authors have no conflicts to disclose.


© 2023  THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 11 - N° 1

P. 79-87 - janvier 2024 Retour au numéro
Article précédent Article précédent
  • Expectancy Does Not Predict 18-month Treatment Outcomes with Cognitive Training in Mild Cognitive Impairment
  • Jeffrey N. Motter, S.N. Rushia, M. Qian, C. Ndouli, A. Nwosu, J.R. Petrella, P.M. Doraiswamy, T.E. Goldberg, D.P. Devanand
| Article suivant Article suivant
  • Lifestyle and Socioeconomic Transition and Health Consequences of Alzheimer’s Disease and Other Dementias in Global, from 1990 to 2019
  • Y. Cui, W. Yang, J. Shuai, Y. Ma, Yan Yan

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.